General Hospital's Ingo Rademacher to welcome new baby

Posted Wednesday, February 03, 2021 12:48:40 PM
Vertical GH Soap Banner

General Hospital star Ingo Rademacher (Jasper "Jax" Jacks) and his wife, Ehiku, are expecting their third child.

Congratulations are in order for General Hospital star Ingo Rademacher (Jasper "Jax" Jacks), who is thrilled to announce that he and his wife, Ehiku, are expanding their family.

The actor took to Instagram with the exciting news. "Happy to announce we're soon going to be a family of 5 + ," Rademacher shared along with the joke, "#junebaby say goodby to your tiny ass bougie Range Rover and embrace that Minivan we need now honey. @ehiku Car ideas are welcome. 5 people and a dog. 5 hr trips to Mammoth, AWD [all-wheel drive] required."

Rademacher and Ehiku have two sons, Peanut Kai, who was born in 2008, and Pohaku Zen, born in 2012. Will they soon have a baby brother -- or a baby sister? If the actor knows the sex of his baby, he's keeping it under wraps for now. When one fan commented that he's going to have a little girl, he simply responded, "We'll see."

If the actor does have his first daughter, his GH costar Marcus Coloma (Nikolas Cassadine) shared some wisdom: "In my experience, daughters give you all the advice you need," he wrote. "Just the absolute best, enjoy every moment. You know how fast it goes!"

View this post on Instagram

A post shared by Ingo Rademacher (@ingorademacher)

Ingo Rademacher has been playing GH's Jax on-again, off-again since 1996. He also briefly played the role of The Bold and the Beautiful's Thorne Forrester from 2017 to 2018.

Would you like to leave a congratulatory message for GH's Ingo Rademacher? How do you feel about the actor and his wife getting ready to welcome baby number three? We want to hear from you -- and there are many ways you can share your thoughts.

Post a Comment Share on Facebook Tweet this Submit Feedback
Related Information


© 1995-2021 Soap Central, LLC. Home | Contact Us | Advertising Information | Privacy Policy | Terms of Use | Top